Integra LifeSciences Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Integra LifeSciences (IART) Tops Q1 EPS by 4c
April 24, 2019 6:17 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.65, $0.04 better than the analyst estimate of $0.61. Revenue for the quarter came in at $359.7 million versus the consensus estimate of $360.38 million.
GUIDANCE:
Integra LifeSciences sees FY2019 EPS of $2.65-$2.72, versus the consensus of $2.69.... More
